These results indicated that six core targets of MAPK8, CTNNB1, NFKB1, EGFR, BCL2, and NFE2L2 are associated with AD, indicating good specificity and sensitivity for diagnosing patients, as shown in Table 1. Here, MAPK8 is linked to Alzheimer disease.